Strides Shasun is currently trading at Rs 1328.95, up by 28.25 points or 2.17% from its previous closing of Rs. 1300.70 on the BSE.
The scrip opened at Rs. 1304.00 and has touched a high and low of Rs. 1329.00 and Rs. 1296.05 respectively. So far 25667 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1412.45 on 23-Nov-2015 and a 52 week low of Rs. 822.20 on 10-Feb-2015.
Last one week high and low of the scrip stood at Rs. 1334.80 and Rs. 1255.05 respectively. The current market cap of the company is Rs. 10688.42 crore.
The promoters holding in the company stood at 27.65% while Institutions and Non-Institutions held 44.42% and 27.94% respectively.
Strides Shasun has launched a share sale to raise funds up to Rs 1,500 crore ($225.7 million). The company is selling shares at Rs 1,278 apiece in the transaction, which comprises a base deal for Rs 1,000 crore with an upsize option of Rs 5 crore. Axis and Jefferies are the bookrunners for the deal.
Strides Shasun is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The company has four business verticals, viz., Regulated Markets, Emerging Markets, Institutional Business and Pharmaceutical Services & Active Ingredients.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |